13F COMBINATION REPORT
Syncona Portfolio Ltd
Quarter ended Q3 2023 · Filed July 27, 2023 · Accession 0000950123-23-006361
Total Value
$66.3M
Positions
4
Other Managers
3
Confidential Omitted
No
Holdings (4)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | AUTOLUS THERAPEUTICS PLC | AUTL | 21,346,829 | $50.8M | 76.58% |
| 2 | ACHILLES THERAPEUTICS PLC | 00449L102 | 11,086,909 | $10.5M | 15.80% |
| 3 | FREELINE THERAPEUTICS HLDGS | 35655L107 | 1,466,508 | $3.8M | 5.70% |
| 4 | ADAPTIMMUNE THERAPEUTICS PLC | ADTI | 1,377,294 | $1.3M | 1.92% |